Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still\textquoterights disease

  Cem Gabay ^{1, 2} AuthorId : 802439
Author

  Bruno Fautrel ^{3, 4} AuthorId : 253661
Author

  Jürgen Rech AuthorId : 11280969
Author

  François Spertini ⁵ AuthorId : 11280970
Author

  Eugen Feist AuthorId : 11280971
Author

  Ina Kötter ⁶ AuthorId : 11280972
Author

  Eric Hachulla ⁷ AuthorId : 238132
Author

  Jacques Morel ⁸ AuthorId : 474053
Author

  Thierry Schaeverbeke ⁹ AuthorId : 84804
Author

  Mohamed Hamidou ^{10, 11, 12} AuthorId : 701032
Author

  Thierry Martin ¹³ AuthorId : 57055

Author IdHAL : thierry-martin

  Bernhard Hellmich AuthorId : 11280973
Author

  Peter Lamprecht AuthorId : 11280974
Author

  Hendrik Schulze-Koops AuthorId : 11269900
Author

  Delphine Sophie Courvoisier AuthorId : 11280975
Author

  Andrew Sleight AuthorId : 11280976
Author

  Eduardo Jorge Schiffrin AuthorId : 11280977
Author